123 related articles for article (PubMed ID: 15580283)
1. Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues.
Yang XA; Dong XY; Qiao H; Wang YD; Peng JR; Li Y; Pang XW; Tian C; Chen WF
Lab Invest; 2005 Feb; 85(2):205-13. PubMed ID: 15580283
[TBL] [Abstract][Full Text] [Related]
2. Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients.
Dong XY; Su YR; Qian XP; Yang XA; Pang XW; Wu HY; Chen WF
Br J Cancer; 2003 Jul; 89(2):291-7. PubMed ID: 12865919
[TBL] [Abstract][Full Text] [Related]
3. TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma.
Yin YH; Li YY; Qiao H; Wang HC; Yang XA; Zhang HG; Pang XW; Zhang Y; Chen WF
Br J Cancer; 2005 Aug; 93(4):458-63. PubMed ID: 16106251
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
Chen Y; Huang A; Gao M; Yan Y; Zhang W
Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
[TBL] [Abstract][Full Text] [Related]
5. HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma.
Li B; Qian XP; Pang XW; Zou WZ; Wang YP; Wu HY; Chen WF
Lab Invest; 2003 Aug; 83(8):1185-92. PubMed ID: 12920247
[TBL] [Abstract][Full Text] [Related]
6. Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas.
Yutani S; Shichijo S; Inoue Y; Kawagoe N; Okuda K; Kurohiji T; Tanaka M; Sata M; Itoh K
Oncol Rep; 2001; 8(2):369-72. PubMed ID: 11182058
[TBL] [Abstract][Full Text] [Related]
7. Cancer-testis antigen GAGE-1 expression and serum immunoreactivity in hepatocellular carcinoma.
Chao NX; Li LZ; Luo GR; Zhong WG; Huang RS; Fan R; Zhao FL
Niger J Clin Pract; 2018 Oct; 21(10):1361-1367. PubMed ID: 30297572
[TBL] [Abstract][Full Text] [Related]
8. Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients.
Dong XY; Yang XA; Wang YD; Chen WF
Br J Cancer; 2004 Oct; 91(8):1566-70. PubMed ID: 15354214
[TBL] [Abstract][Full Text] [Related]
9. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
10. Expression of cancer-testis antigens in hepatocellular carcinoma.
Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY
World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429
[TBL] [Abstract][Full Text] [Related]
11. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY
Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222
[TBL] [Abstract][Full Text] [Related]
12. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
[TBL] [Abstract][Full Text] [Related]
13. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF
Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723
[TBL] [Abstract][Full Text] [Related]
14. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
Luo B; Yun X; Li J; Fan R; Guo WW; Liu C; Lin YD; Ge YY; Zeng X; Bi SQ; Nong WX; Zhang QM; Xie XX
Curr Med Sci; 2020 Aug; 40(4):719-728. PubMed ID: 32862383
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM
Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma antigen 1 and 2 mRNA and a new variant expressed in hepatocellular carcinoma.
Li S; Gao Y; Yang B; Liang Z; Wang Y; Zhai D; Jing L; Liu T; Wang F; DU Z; Wang Y
Neoplasma; 2014; 61(6):718-23. PubMed ID: 25150316
[TBL] [Abstract][Full Text] [Related]
17. Purification and refolding of a novel cancer/testis antigen BJ-HCC-2 expressed in the inclusion bodies of Escherichia coli.
Yang XA; Dong XY; Li Y; Wang YD; Chen WF
Protein Expr Purif; 2004 Feb; 33(2):332-8. PubMed ID: 14711522
[TBL] [Abstract][Full Text] [Related]
18. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis.
Huang X; Ji G; Wu Y; Wan B; Yu L
J Cancer Res Clin Oncol; 2008 Jun; 134(6):705-14. PubMed ID: 18084776
[TBL] [Abstract][Full Text] [Related]
19. Lewis Y antigen expression in hepatocellular carcinoma. An immunohistochemical study.
Wakabayashi M; Shiro T; Seki T; Nakagawa T; Itoh T; Imamura M; Shiozaki Y; Inoue K; Okamura A
Cancer; 1995 Jun; 75(12):2827-35. PubMed ID: 7539714
[TBL] [Abstract][Full Text] [Related]
20. Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Bricard G; Bouzourene H; Martinet O; Rimoldi D; Halkic N; Gillet M; Chaubert P; Macdonald HR; Romero P; Cerottini JC; Speiser DE
J Immunol; 2005 Feb; 174(3):1709-16. PubMed ID: 15661935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
